Recent research has identified a specific biological mechanism that may explain why females experience more severe ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...

New research shows that aging blood can accelerate Alzheimer’s-like changes in the brain, while younger blood may offer ...

Alzheimer’s disease is usually confirmed through brain scans or spinal fluid tests, which are invasive and expensive ...

A new analysis suggests most Alzheimer’s cases depend on the APOE gene, making it a major target for prevention and treatment ...

Alzheimer’s disease has long been the nightmare diagnosis that medicine could slow at best, not stop. Now a wave of ...

A new blood test that detects Alzheimer’s by taking a sample from a finger prick could diagnose the disease at early stages long before symptoms become severe, a new Europe-wide study found.The new ...

Stem cell treatment targeting the bone beneath the knee reduced pain and improved movement more effectively than joint ...

KeifeRx, a privately held biotechnology company developing disease-modifying therapies for neurodegenerative disorders, today announced that it has entered into a research collaboration and option ...

Fannin Partners has been awarded a $300,000 Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute (NEI) to advance a first-in-class, non-VEGF–targeted therapeutic for ...

Alzheimer’s disease is the most common cause of dementia and most often affects individuals older than 60. Image: PSJ Design ...

People carrying at least one APOE4 allele have a higher risk of Alzheimer's disease. People who carry two alleles have the highest risk, leading some researchers to suggest that APOE4 homozygotes have ...